Status:
UNKNOWN
Pelvic Floor Muscle Training in the Treatment of Erectile Dysfunction
Lead Sponsor:
Herlev and Gentofte Hospital
Conditions:
Erectile Dysfunction
Eligibility:
MALE
30-70 years
Phase:
NA
Brief Summary
Erectile dysfunction affects about 40% of all men above the age of 40 and the prevalence increases with increasing age. It is not possible to cure the condition as current forms of treatment are aimed...
Eligibility Criteria
Inclusion
- Erectile Dysfunction for more than 6 months
- IIEF-EF score \< 25
- In a stable heterosexual relationship in minimum of 3 months (since all questionnaires are only validated for heterosexuals)
Exclusion
- Known psychiatric, neurological, and/or endocrine disorders (including hypogonadism with total testosterone \<12 nmol / l)
- Traumatic nerve damage
- Diabetes
- Previous surgery or radiotherapy in the pelvic region
- Nerve disorders that prevent nerve connection to the pelvic floor muscles
- Severe heart disease in the form of unstable angina, NYHA class \> II heart failure, uncontrolled arrhythmia or severe symptomatic and/or severe valvular disease
- Use of anti-androgen drugs Peyronie's disease and/or previous cases of priapism
- Alcohol overconsumption (more than 21 items per week)
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05385822
Start Date
May 1 2022
End Date
March 1 2025
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urological Research Unit
Herlev, Capital Region, Denmark, 2730